<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2016-2-19-24</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-529</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>СЕРДЕЧНО-СОСУДИСТЫЕ ОСЛОЖНЕНИЯ И СОСТОЯНИЕ УГЛЕВОДНОГО ОБМЕНА ПРИ КОРОНАРНОМ ШУНТИРОВАНИИ НА “РАБОТАЮЩЕМ СЕРДЦЕ” В ЗАВИСИМОСТИ ОТ РЕЖИМА САХАРОСНИЖАЮЩЕЙ ТЕРАПИИ У БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА И САХАРНЫМ ДИАБЕТОМ 2 ТИПА</article-title><trans-title-group xml:lang="en"><trans-title>CARDIOVASCULAR COMPLICATIONS AND CARBOHYDRATE METABOLISM IN CORONARY SHUNTING “OFF-PUMP” ACCORDING TO THE REGIMEN OF GLUCOSE LOWERING TREATMENT IN ISCHEMIC HEART DISEASE AND DIABETES</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бородашкина</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Borodashkina</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>зав. областным кардиологическим диспансером, врач- кардиолог,</p><p>Иркутск</p></bio><bio xml:lang="en"><p>Irkutsk</p></bio><email xlink:type="simple">chernigas@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Подкаменный</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Podkamenny</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор кафедры сердечно-сосудистой хирургии и клинической ангиологии, сердечно-сосудистый хирург,</p><p>Иркутск</p></bio><bio xml:lang="en"><p>Irkutsk</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Протасов</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Protasov</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор кафедры терапии и кардиологии, прорек- тор по научной работе,</p><p>Иркутск</p></bio><bio xml:lang="en"><p>Irkutsk</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ Иркутская ордена “Знак почета” областная клиническая больница</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Irkutsk “Honor Award” Regional Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБОУ ДПО Иркутская государственная медицинская академия последипломного образования Минздрава России</institution><country>Russian Federation</country></aff><aff xml:lang="en"><institution>Irkutsk State Medical Academy of Postgraduate Education of the Ministry of Health</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>28</day><month>02</month><year>2016</year></pub-date><volume>0</volume><issue>2</issue><issue-title>РОССИЙСКИЙ КАРДИОЛОГИЧЕСКИЙ ЖУРНАЛ</issue-title><fpage>19</fpage><lpage>24</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бородашкина С.Ю., Подкаменный В.А., Протасов К.В., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Бородашкина С.Ю., Подкаменный В.А., Протасов К.В.</copyright-holder><copyright-holder xml:lang="en">Borodashkina S.Y., Podkamenny V.A., Protasov K.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/529">https://russjcardiol.elpub.ru/jour/article/view/529</self-uri><abstract><sec><title>Цель</title><p>Цель. Изучить ближайшие результаты коронарного шунтирования (КШ) на “работающем сердце” и состояние углеводного обмена у больных ишемической болезнью сердца (ИБС) с сопутствующим сахарным диабетом 2 типа (СД 2) при различных режимах периоперационной сахароснижающей терапии.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В исследование включены больные ИБС с СД 2, получающие пероральные сахароснижающие препараты (ПССП). Средний возраст составил 57,5 (53-62) лет. Мужчин было 99 (78,6%). Перед операцией больные были рандомизированы в группы ПССП (n=61) и инсулина (ИН) (n=65). В группе ПССП прием препаратов продолжался в периоперационном периоде. В группе ИН осуществлялся перевод на ИН короткого действия. Изучали динамику показателей углеводного обмена в различные временные интервалы периоперационного периода и ее взаимосвязь с режимом сахароснижающей терапии. Анализировали частоту ранних послеоперационных сердечно-сосудистых осложнений (ССО): инфаркт миокарда, инсульт, фибрилляция предсердий. Сравнивали показатели углеводного обмена в подгруппах больных с ССО и без них.</p></sec><sec><title>Результаты</title><p>Результаты. Исходно параметры углеводного обмена не отличались в обеих группах. На фоне введения ИН среднесуточные уровни глюкозы, ее вариабельность в течение суток, а также доля значений гликемии, меньших рекомендуемого периоперационного диапазона (6,1-10,0 ммоль/л), были больше, чем в группе ПССП. Общее количество ССО также преобладало в группе ИН (20,0% против 8,2%, р=0,049). Подгруппы больных с осложнениями и без них статистически значимо отличались по исходному уровню гликированного гемоглобина, среднему уровню глюкозы и ее вариабельности в течение суток во всех изучаемых временных интервалах, а также по частоте отклонений глюкозы &lt;6,1 ммоль/л за сутки перед операцией, до — и сразу после нее.</p></sec><sec><title>Заключение</title><p>Заключение. У больных, перенесших операцию КШ на “работающем сердце”, при переводе на ИН короткого действия, по сравнению с продолжавшими прием ПССП пациентами, отмечено повышение среднего уровня гликемии, ее вариабельности и частоты отклонений от рекомендуемого диапазона, а также более частое развитие послеоперационных сердечно-сосудистых осложнений.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To study the shortest term results of coronary bypass (CBG) under “off-pump” circumstances and the condition of carbohydrate metabolism in ischemic disease patients (IHD) with comorbid diabetes 2 type (DM2) under various regimens of perioperation glucose lowering therapy.</p></sec><sec><title>Material and methods</title><p>Material and methods. In the study, the IHD and DM2 patients included, receiving oral glucose lowering drugs (OGLD), with the mean age 57,5 (53-62) y.o., men 99 (78,6%). Before operation the patients were selected to the groups of OGLD (n=61) and insulin (IN) (n=65). In OGLD group the intake of the drugs was continued during perioperation period. In the IN group there was switch to short insulin. The dynamics of carbohydrate metabolism markers in different timeline intervals of postoperation period was studied, and its relation with the glucose lowering regimen. The early postoperation cardiovascular complications (CVC) rate was measured: myocardial infarction, stroke, atrial fibrillation. The carbohydrate metabolism parameters in subgroups of patients was measured, with CVC and without.</p></sec><sec><title>Results</title><p>Results. At baseline there were no differences in carbohydrate metabolism parameters in groups. Loading IN, mean daily glucose levels, its variability and glycemia below the recommended perioperation range (6,1-10,0 mM/L) were lower than in OGLD group. Total number of CVC also predominated in IN group (20,0% vs. 8,2%, p=0,049). Complication subgroups and non-complicated, significantly differed by the baseline glycosilated hemoglobin, mean level of glucose and its daily variability in all timeline intervals studied, as by the prevalence of glucose &lt;6,1 mM/L 0ne day before operation, just before and just after.</p></sec><sec><title>Conclusion</title><p>Conclusion. Patients underwent CBG as off-pump, after switch on short IN, comparing to OGLD patients, have higher mean glycemia level, its variability and number of shifts from recommended range, as higher rate of post-operation CVC.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>коронарное шунтирование</kwd><kwd>сахарный диабет</kwd><kwd>пероральные сахароснижающие препараты</kwd><kwd>инсулин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>coronary bypass</kwd><kwd>diabetes mellitus</kwd><kwd>oral glucose lowering drugs</kwd><kwd>insulin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">The BARI 2D Study Group: A randomized trial of therapies for type 2 diabetes and coronary artery disease. N. Engl J Med. 2009; 360: 2503-15.</mixed-citation><mixed-citation xml:lang="en">The BARI 2D Study Group: A randomized trial of therapies for type 2 diabetes and coronary artery disease. N. Engl J Med. 2009; 360: 2503-15.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bansilal S, Farkouh ME, Hueb W. The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and an-giographic profile at study entry. Am Heart J. 2012; 164 (4): 591-9.</mixed-citation><mixed-citation xml:lang="en">Bansilal S, Farkouh ME, Hueb W. The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and an-giographic profile at study entry. Am Heart J. 2012; 164 (4): 591-9.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Dedov II, Shestakova MV. Algorithms of specialized medical care by sick diabetes", 7th re-lease. Diabetes mellitus. 2015; 18 (1S): 1-112. (Дедов И. И., Шестакова М. В. Алгоритмы спе-циализированной медицинской помощи больным сахарным диабетом», 7 выпуск. Сахарный диабет. 2015; 18 (1S): 1-112.)</mixed-citation><mixed-citation xml:lang="en">Dedov II, Shestakova MV. Algorithms of specialized medical care by sick diabetes", 7th re-lease. Diabetes mellitus. 2015; 18 (1S): 1-112. (Дедов И. И., Шестакова М. В. Алгоритмы спе-циализированной медицинской помощи больным сахарным диабетом», 7 выпуск. Сахарный диабет. 2015; 18 (1S): 1-112.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veter-ans with type 2 diabetes. N Engl J Med. 2009; 360 (2): 129-39.</mixed-citation><mixed-citation xml:lang="en">Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veter-ans with type 2 diabetes. N Engl J Med. 2009; 360 (2): 129-39.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Skyler JS, Bergenstal R, Bonow BO, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009; 32: 187-92.</mixed-citation><mixed-citation xml:lang="en">Skyler JS, Bergenstal R, Bonow BO, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009; 32: 187-92.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest. 2010; 137: 544-51.</mixed-citation><mixed-citation xml:lang="en">Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest. 2010; 137: 544-51.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012; 40: 3251-76.</mixed-citation><mixed-citation xml:lang="en">Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012; 40: 3251-76.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. J Am Coll Cardiol. 2014; 64 (22): 77-137.</mixed-citation><mixed-citation xml:lang="en">2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. J Am Coll Cardiol. 2014; 64 (22): 77-137.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Guidelines on myocardial revascularization. Eur Heart J. 2010; 31: 2501-55.</mixed-citation><mixed-citation xml:lang="en">Guidelines on myocardial revascularization. Eur Heart J. 2010; 31: 2501-55.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Dedov II, Shestakova MV, Maksimova MA. Federal target program "Diabetes". Methodical recommendations. 2002. (Дедов И. И., Шестакова М. В., Максимова М. А. Федеральная целевая программа «Сахарный диабет». Методические рекомендации. 2002).</mixed-citation><mixed-citation xml:lang="en">Dedov II, Shestakova MV, Maksimova MA. Federal target program "Diabetes". Methodical recommendations. 2002. (Дедов И. И., Шестакова М. В., Максимова М. А. Федеральная целевая программа «Сахарный диабет». Методические рекомендации. 2002).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Roques F, Michel P, Goldstone A, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur Heart J. 2003; 24: 882-3.</mixed-citation><mixed-citation xml:lang="en">Roques F, Michel P, Goldstone A, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur Heart J. 2003; 24: 882-3.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">ESC Third Universal Definition of Myocardial Infarction. Eur Heart J. 2012; 33: 2551-67.</mixed-citation><mixed-citation xml:lang="en">ESC Third Universal Definition of Myocardial Infarction. Eur Heart J. 2012; 33: 2551-67.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">U.K. Hypoglycaemia Study Group: Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia. 2007; 50: 1140-7.</mixed-citation><mixed-citation xml:lang="en">U.K. Hypoglycaemia Study Group: Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia. 2007; 50: 1140-7.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Komissarovа ES. Selection of the optimal level of glycemia in surgical patients with type 2 diabetes who are in the ICU and intensive therapy. Abstract. 2014; 1-26. (Комиссарова Е.С. Выбор оптимального уровня гликемии у больных хирургического профиля с сахарным диабетом 2 типа, находящихся в отделении реанимации и интенсивной терапии. Автореф. дисс. канд. мед. наук. 2014; 1-26.)</mixed-citation><mixed-citation xml:lang="en">Komissarovа ES. Selection of the optimal level of glycemia in surgical patients with type 2 diabetes who are in the ICU and intensive therapy. Abstract. 2014; 1-26. (Комиссарова Е.С. Выбор оптимального уровня гликемии у больных хирургического профиля с сахарным диабетом 2 типа, находящихся в отделении реанимации и интенсивной терапии. Автореф. дисс. канд. мед. наук. 2014; 1-26.)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Subramaniam B, Lerner A, Novack V, et al. Increased Glycemic Variability in Patients with Elevated Preoperative HbA1c Predicts Adverse Outcomes Following Coronary Artery Bypass Grafting Surgery. Anesth Analg. 2014; 118 (2): 277-87.</mixed-citation><mixed-citation xml:lang="en">Subramaniam B, Lerner A, Novack V, et al. Increased Glycemic Variability in Patients with Elevated Preoperative HbA1c Predicts Adverse Outcomes Following Coronary Artery Bypass Grafting Surgery. Anesth Analg. 2014; 118 (2): 277-87.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
